Express Scripts (ESRX) has generated one of the best records of consistent earnings growth on the planet. As one of the largest pharmacy benefit management companies in the country, Express Scripts is a great demographic play considering the Graying of America. Furthermore, now that the odds that their $29 billion merger with Medco (MHS) will go through, Express Scripts will be positioned as an even stronger player in this rapidly growing segment. It’s also important to note that Medco also has a long history of consistent earnings growth. Therefore, the combined companies should complement each other extremely well. Consequently, investors seeking maximum capital appreciation by investing in a high-quality company with a bright future might look no farther than Express Scripts.

(Click here to read full article on Seeking Alpha.)